Evidence map›Paper›PMID 37891240›Full record

ArticleScientific reports2023

Investigating microRNAs as biomarkers in disorders of consciousness: a longitudinal multicenter study.

Nicolò Musso, Dalida Bivona, Carmelo Bonomo, Paolo Bonacci, Maria Enza D'Ippolito, Cristina Boccagni, Francesca Rubino, Antonio De Tanti, Lucia Francesca Lucca, Valeria Pingue and 5 more

Abstract readMulticenter Study
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. MiRNA Dysregulation in Brain Injury: AnCurrent neuropharmacology · 2025
    Article
  5. Review
  6. How MicroRNAs Command the Battle against Cancer.International journal of molecular sciences · 2024
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Nicolò Musso *Department of Biomedical and Biotechnological Sciences, University of Catania, 95123, Catania, Italy.
Dalida Bivona *Department of Biomedical and Biotechnological Sciences, University of Catania, 95123, Catania, Italy.
Carmelo BonomoDepartment of Biomedical and Biotechnological Sciences, University of Catania, 95123, Catania, Italy.
Paolo BonacciDepartment of Biomedical and Biotechnological Sciences, University of Catania, 95123, Catania, Italy.
Maria Enza D'IppolitoMolecular Biology Laboratory, Giuseppe Giglio Foundation, 90015, Cefalù, Italy.
Cristina BoccagniUnit of Neurophysiology and Unit for Severe Acquired Brain Injuries, Giuseppe Giglio Foundation, 90015, Cefalù, Italy.
Francesca RubinoUnit of Neurophysiology and Unit for Severe Acquired Brain Injuries, Giuseppe Giglio Foundation, 90015, Cefalù, Italy.
Antonio De TantiCardinal Ferrari Center, 43012, Fontanellato, Italy.
Lucia Francesca LuccaRAN (Research in Advanced Neuro-Rehabilitation), S. Anna Institute, 80067, Crotone, Italy.
Valeria PingueNeurorehabilitation and Spinal Units, Istituti Clinici Scientifici Maugeri IRCCS, 27100, Pavia, Italy.
Valentina ColomboMontecatone Rehabilitation Institute, 40026, Imola, Italy.
Anna EstraneoDon Gnocchi Foundation IRCCS, 50124, Florence, Italy.
Stefania StefaniDepartment of Biomedical and Biotechnological Sciences, University of Catania, 95123, Catania, Italy.
Maria AndrioloClinical Pathology Laboratory, Provincial Health Authority of Caltanissetta, 93100, Caltanissetta, Italy.
Sergio BagnatoUnit of Neurophysiology and Unit for Severe Acquired Brain Injuries, Giuseppe Giglio Foundation, 90015, Cefalù, Italy. sergiobagnato@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MicroRNAs (miRNAs) are involved in gene regulation and may affect secondary brain injury and recovery in patients with disorders of consciousness (DoC). This study investigated the role of five miRNAs (150-5p, 132-3p, 23b-3p, 451a, and 16-5p) in prolonged DoC. miRNA levels were assessed in serum samples from 30 patients with unresponsive wakefulness syndrome or minimally conscious state due to traumatic or hypoxic-ischemic brain injury (TBI, HIBI) at baseline (1-3 months) and 6 months post-injury. Patients' diagnoses were determined using the Coma Recovery Scale revised, and functional outcomes were evaluated 6 months after injury with the Glasgow Outcome Scale Extended (GOSE) and the Functional Independence Measure (FIM). Compared to healthy controls, patients with TBI had lower levels of miRNAs 150-5p, 132-3p, and 23b-3p at baseline, while patients with HIBI had lower levels of miRNA 150-5p at baseline and 6 months post-injury and a reduction of miRNA 451a at baseline. Higher levels of miRNAs 132-3p and 23b-3p were associated with better outcomes in TBI patients as indicated by GOSE and FIM scores. This study highlights distinct miRNA dysregulated patterns in patients with prolonged DoC, dependent on etiology and post-injury time, and suggests that miRNAs 132-3p and 23b-3p may serve as prognostic biomarkers.

Indexed as

Brain InjuriesMicroRNAsBiomarkersComaConsciousness DisordersHumansBiomarkersMicroRNAsMIR150, human

Identifiers

PMID37891240
PMCPMC10611795

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.